United States · Federal contract register · Supplier record

BIOLEGEND, INC.

Line: Drugs and biologicals (6505)Register loaded to November 2025Compiled 17 October 2026

BIOLEGEND, INC. — United States · Federal contract register · Supplier record: 186 contracts, all years ($2,596,191 · Oct 2007 – May 2026); $352K since January 2024 (17 contracts · 1 agency); 251st rank in the line (of 514 suppliers · 0.0%); 8 agencies never served ($380M on the line without BIOLEGEND, INC.).

Assay record ASY-US-03UYOD01UG · Cite as: Assay Systems, “BIOLEGEND, INC.: 17 government contracts in the United States since 2024”, https://assay-systems.com/register/us/biolegend-inc/

186
contracts, all years
$2,596,191 · Oct 2007 – May 2026
$352K
since January 2024
17 contracts · 1 agency
251st
rank in the line
of 514 suppliers · 0.0%
8
agencies never served
$380M on the line without BIOLEGEND, INC.

Own record by year

2019 onward
$248K
$221K
$357K
$171K
$413K
$104K
$209K
$39.2K
20192020202120222023202420252026

Who buys from BIOLEGEND, INC.

since January 2024
1agencies
$352Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$351,559

Before 2024 only: Department of Agriculture, Department of Defense, Department of Veterans Affairs.

Won without a rival

2023-12-01 – 2026-05-14
16uncontested awards
80%of its awards
12without a competition
4single bid

BIOLEGEND, INC won 16 of its 20 public contract awards in United States without a rival from 2023-12-01 to 2026-05-14, worth $274K: 12 without a competition and 4 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest National Institutes of Health with 16.

Buyers: National Institutes of Health (16)

Every uncontested award of BIOLEGEND, INC · United States: all uncontested awards

The line

since January 2024
$28.2Bline value
158,923contracts
12agencies
514suppliers
96.4%held by top ten

Drugs and biologicals (6505)

$15.1B
$13.2B
20242025Jan–Nov
251stof 514 suppliers
$183,154BIOLEGEND, INC. in the line
0.0%share of the line
0.0%of $1,770,840,157 spent by Department of Health and Human Services

Agencies that buy the line and never bought from BIOLEGEND, INC.

8agencies
3,848contracts
$379,504,729since January 2024
Department of Justice3,446 contracts
$367,934,841
Department of State233 contracts
$8,285,468
Peace Corps158 contracts
$2,977,299
Department of Homeland Security5 contracts
$127,122
Department of the Interior2 contracts
$89,569
Department of the Treasury2 contracts
$50,300
Environmental Protection Agency1 contract
$27,529
Court Services and Offender Supervision Agency1 contract
$12,600

How the line is bought

by value, since 2024
2%no competition
1%one applicant
0of these to BIOLEGEND, INC.
Competed, several suppliers applied155,553 contracts
$27,183,879,004 · 96.4%
Awarded directly, no competition1,490 contracts
$630,011,719 · 2.2%
Competed, one supplier applied1,880 contracts
$393,572,998 · 1.4%

Contracts reaching their end dates

Oct 2026 – October 2027
81contracts
$633,969,668end by October 2027
22end in August 2027 · $39.5M
$10.8M
$3.8M
$4.5M
$34.2M
$2.8M
$1.4M
$38.9M
$447M
$1.2M
$39.5M
$49.6M
Oct 2618 contractsNov 269 contractsDec 265 contractsFeb 274 contractsMar 277 contractsApr 273 contractsMay 275 contractsJun 274 contractsJul 272 contractsAug 2722 contractsSep 272 contracts

Suppliers next to it in the line

since January 2024
BIOLEGEND, INC.
$183,154
LIFE TECHNOLOGIES CORPORATION5 contracts · 1 agency
$180,404
SCRIPTPRO USA INC3 contracts · 2 agencies
$180,155
STEMCELL TECHNOLOGIES INC8 contracts · 1 agency
$178,809

All 514 suppliers in the line

Fastest-growing supplier in the line

same line
+97%growth

Supplier UEI KABZK8W6PQT3

2024 to Nov 2025
$7,051,163,185
2022–2023
$3,579,627,887

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.